To be held at 26TH – 27TH JUNE 2008, BSG CONFERENCE CENTRE, LONDON, UK
India, Republic of (Press Release) May 9, 2008 --
Dear Colleague,
As technology advances and regulations tighten, the competition to get new drugs on to the market has never been fi ercer. The next few years look to be a critical time for the pharmaceutical industry. The development pipeline looks increasingly sparse, so equipping your business with cutting edge technologies and effi cient strategies for drug development and reformulation will be the best way to keep profi ts high. Visiongain’s Dissolution Testing, Bioequivalence & Bioavailability Strategies Conference is packed with the latest updates, insights and practical advice that will equip you with latest drug analysis tools. Whether your company’s strategy for development lies in the extension of product life cycle with novel reformulations, the production of generic alternatives or just increasing effi ciency of existing portfolios; improving the effi cacy of your dissolution testing methods and your bioavailability and bioequivalence studies will help achieve these goals. Dissolution testing methods must keep up with the new challenges posed by poorly soluble and lipophilic drugs. Bioequivalence and bioavailability studies must meet stricter EMEA and FDA guidelines. Successful novel dosage forms and accurate PK-PD modelling must be achieved early in the development cycle. This 2-day event will provide you with an invaluable opportunity to exchange experiences through interactive discussions and hear case studies presented by the industry’s leading professionals.
Reasons to register today:
Identify current method development problems and the associated dosage forms
Develop useful and standardised methods to meet the challenges of new dosage forms
Encourage innovation of new methodologies
Gain a more in depth understanding of the IVIVC Explore new technologies/equipment for in vitro release testing of novel dosage forms
Discuss of validation principles for new and standard methods I look forward to meeting you at the conference Best regards
Best Regards
Andrea Charles
Head of Conferences
For more information kindly visit: http://www.bharatbook.com/seminars/Dissolution-Testing-Bioequivalence-and-Bioavailability-Strategies.asp
As technology advances and regulations tighten, the competition to get new drugs on to the market has never been fi ercer. The next few years look to be a critical time for the pharmaceutical industry. The development pipeline looks increasingly sparse, so equipping your business with cutting edge technologies and effi cient strategies for drug development and reformulation will be the best way to keep profi ts high. Visiongain’s Dissolution Testing, Bioequivalence & Bioavailability Strategies Conference is packed with the latest updates, insights and practical advice that will equip you with latest drug analysis tools. Whether your company’s strategy for development lies in the extension of product life cycle with novel reformulations, the production of generic alternatives or just increasing effi ciency of existing portfolios; improving the effi cacy of your dissolution testing methods and your bioavailability and bioequivalence studies will help achieve these goals. Dissolution testing methods must keep up with the new challenges posed by poorly soluble and lipophilic drugs. Bioequivalence and bioavailability studies must meet stricter EMEA and FDA guidelines. Successful novel dosage forms and accurate PK-PD modelling must be achieved early in the development cycle. This 2-day event will provide you with an invaluable opportunity to exchange experiences through interactive discussions and hear case studies presented by the industry’s leading professionals.
Reasons to register today:
Identify current method development problems and the associated dosage forms
Develop useful and standardised methods to meet the challenges of new dosage forms
Encourage innovation of new methodologies
Gain a more in depth understanding of the IVIVC Explore new technologies/equipment for in vitro release testing of novel dosage forms
Discuss of validation principles for new and standard methods I look forward to meeting you at the conference Best regards
Best Regards
Andrea Charles
Head of Conferences
For more information kindly visit: http://www.bharatbook.com/seminars/Dissolution-Testing-Bioequivalence-and-Bioavailability-Strategies.asp
Email
Print
SPAM
LEAVE A COMMENT
